IL6 and Stroke: Evidence has shown that the pro-inflammatory cytokine IL-6 increases after stroke, and higher IL-6 concentrations during the acute phase (< 7 days) after onset were associated with poor short-term and long-term outcomes in stroke patients [23–25].